找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Essentials of Non-Alcoholic Fatty Liver Disease; Complications and Ex Anca Trifan,Carol Stanciu,Cristina Muzica Book 2023 The Editor(s) (if

[復(fù)制鏈接]
樓主: Conformist
31#
發(fā)表于 2025-3-26 21:41:32 | 只看該作者
32#
發(fā)表于 2025-3-27 03:48:28 | 只看該作者
https://doi.org/10.1007/978-3-319-35083-7malignancies. Due to its frequent association with metabolic syndrome, NAFLD is considered a multisystemic disease, and it is a cause of many non-liver-related malignancies such as colorectal, esophageal, gastric, pancreatic, kidney, and breast cancer. The aim of this review is to summarize the extr
33#
發(fā)表于 2025-3-27 08:41:36 | 只看該作者
Corporate Social Responsibility global health burden worldwide. NAFLD includes the progressive disease spectrum from simple steatosis through nonalcoholic steatohepatitis (NASH) to liver cirrhosis and hepatocarcinoma. Morbimortality is linked to the liver disease itself and to extrahepatic complications related to NAFLD and metab
34#
發(fā)表于 2025-3-27 11:21:26 | 只看該作者
35#
發(fā)表于 2025-3-27 14:24:57 | 只看該作者
36#
發(fā)表于 2025-3-27 18:30:43 | 只看該作者
http://image.papertrans.cn/e/image/315673.jpg
37#
發(fā)表于 2025-3-27 22:10:42 | 只看該作者
38#
發(fā)表于 2025-3-28 05:36:29 | 只看該作者
39#
發(fā)表于 2025-3-28 08:55:11 | 只看該作者
https://doi.org/10.1057/9780230801516prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to HCC in the absence of cirrhosis.
40#
發(fā)表于 2025-3-28 13:46:40 | 只看該作者
Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease,prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to HCC in the absence of cirrhosis.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 08:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
屯昌县| 许昌县| 云梦县| 崇明县| 五家渠市| 霍林郭勒市| 来安县| 泰宁县| 子长县| 台山市| 许昌市| 临泽县| 六枝特区| 佛坪县| 安徽省| 杂多县| 台中县| 锡林浩特市| 南雄市| 上虞市| 乡宁县| 东海县| 历史| 安仁县| 于田县| 吉安县| 临潭县| 新余市| 祥云县| 永兴县| 凯里市| 陆河县| 桓台县| 剑阁县| 克什克腾旗| 新民市| 大连市| 繁昌县| 台州市| 平和县| 胶州市|